Speaker Profile
Ph.D., Chief Scientific Officer, Nature's Toolbox (NTx)
Biography
Dr. Steven Evans is the Chief Scientific Officer at NTx, bringing over 20 years of innovation-driven drug discovery and development experience across multiple therapeutic modalities and disease indications. He has been pivotal in advancing solutions that bridge the gap between cutting-edge research and clinical application. NTx has made significant strides in continuous flow synthesis, leading to the production of next-generation RNA and protein platforms. These advancements offer the speed and scalability necessary to cost-effectively address unmet needs, from global pandemic responses to personalized precision medicines. Dr. Evans has authored numerous peer-reviewed publications and holds several patents in the field.
Talk
Revolutionizing Biomanufacturing: Rapidly Deployable Continuous Flow RNA Manufacturing Platform
Natures Toolbox (NTx) develops innovative biomanufacturing solutions like the NTxscribe platform, a proprietary continuous-flow IVT system using hollow fiber bioreactors. Designed for cost-effective, flexible, and rapid mRNA production, it supports distributed manufacturing models, modernizing RNA production with improved speed, quality, and adaptability to meet growing vaccine and therapeutic demands.
Emerging Therapeutics Showcase:
Nature's Toolbox (NTx)
NTx, based in Rio Rancho, NM, is developing innovative systems like NTxpress® and NTxscribe® to enable manufacturing of mRNA vaccines and protein therapeutics in an eco-friendly and sustainable way. These easily scalable processes enable NTx’s platform to scale from personalized medicine dosage to pandemic volume.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
